Glatiramer acetate is an immunomodulator drug currently used to treat multiple
sclerosis. It is a random polymer of four amino acids found in myelin basic protein
Mar 15, 2016 ... Glatiramer is used to reduce episodes of symptoms in patients with relapsing-
remitting forms (course of disease where symptoms flare up from ...
Glatiramer acetate, the active ingredient of COPAXONE, consists of the acetate
salts of synthetic polypeptides, containing four naturally occurring amino acids: ...
See associated safety information and benefits of COPAXONE® (glatiramer
acetate injection). Find a dosing schedule that may be right for you.
Jun 19, 2015 ... A generic equivalent of daily Copaxone® (glatiramer acetate, 20 mg), called “
Glatopa”™ (Sandoz, a Novartis company, developed in ...
Medscape - Indication-specific dosing for Copaxone, Glatopa (glatiramer),
frequency-based adverse effects, comprehensive interactions, contraindications,
This medication is taken by injection. Description. Glatiramer acetate is a
synthetic protein that simulates myelin basic protein, a component of the myelin
Apr 16, 2015 ... The U.S. Food and Drug Administration today approved the first generic version
of Copaxone (glatiramer acetate injection), used to treat ...
Find patient medical information for glatiramer subcutaneous on WebMD
including its uses, side effects and safety, interactions, pictures, warnings and
Jun 10, 2016 ... Consumer information about glatiramer (Copaxone, Glatopa), a multiple sclerosis
(MS) drug prescribed to treat people with relapsing forms of ...